Bdenza – Prostate Cancer Treatment

oncology  /  Bdenza

Bdenza

Bdenza (Enzalutamide) is a medication used for the treatment of prostate cancer, providing a modern approach to disease control and improving the quality of life for patients. Bdenza contains the act... Bdenza (Enzalutamide) is a medication used for the treatment of prostate cancer, providing a modern approach to disease control and improving the quality of life for patients. Bdenza contains the active ingredient enzalutamide, which belongs to the group of androgen receptor inhibitors. It blocks the action of male hormones (androgens) that stimulate the growth of cancer cells in the prostate gland. The medication is used to treat metastatic castration-resistant prostate cancer as well as non-metastatic forms in patients whose disease continues to progress despite low testosterone levels. Bdenza helps slow the progression of the disease, reduce PSA levels, and delay the development of complications associated with cancer spread. It is taken orally, usually once daily, with or without food, making it convenient for patients to adhere to treatment. The medication is generally well tolerated, though side effects such as fatigue, back pain, hot flashes, hypertension, and rare neurological changes like seizures may occur. During treatment with Bdenza, it is important to remain under regular medical supervision and to monitor blood pressure and liver function. The use of Bdenza is part of comprehensive prostate cancer treatment, allowing patients to improve both the duration and quality of life with this diagnosis. Before starting therapy, it is necessary to consult with an oncologist to determine the appropriate treatment plan and to assess potential risks. Read more Hide

• Active ingredient:
  Enzalutamide
• Manufacturer: BDR
• Dosage: 40 mg
• Dosage form: Capsules
• Units per pack: 112
• Delivery across Ukraine
• 100% original product